Working… Menu

Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients (FSHD1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01116570
Recruitment Status : Completed
First Posted : May 5, 2010
Last Update Posted : April 1, 2015
Association Française contre les Myopathies (AFM), Paris
Örebro University, Sweden
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Saint Etienne

Brief Summary:
It is now accepted that physical activity is not deleterious in myopathies, including muscular dystrophies. In patients suffering from facioscapulohumeral dystrophy (FSHD), aerobic training has been reported to be associated to physiological and functional positive effects without alteration in quality of life. The review papers from Van der Kooi et al. (2005), Cup et al. (2007) and Féasson et al. (2010) suggest that the combination of endurance and strength training is even more relevant. Only a few controlled and randomized studies have been conducted on this topic. The impact of such training programs on the skeletal muscle regenerative capacities has not been yet addressed. Moreover, due to the fact that training programs are mainly performed on short-term supervised periods, there is a lack of knowledge regarding long-term effects, patient's autonomy and whether or not regular exercise practice can be maintained in patient's daily life. Also, only a few experiments have reported an integrative view of the potential benefits of such programs on functional, biological and quality of life.

Condition or disease Intervention/treatment Phase
Muscular Dystrophy, Facioscapulohumeral Other: Physical training Other: Control Not Applicable

Detailed Description:

Our research project aims at establishing a program of physical training that will fulfill the two following conditions: (i) being compatible with the daily professional, social and family activity of the patients so it can be integrated in their life habits and (ii) being intensive enough to induce functional benefits. This experimental work will be based on multi-factorial evaluations, i.e. biological, physiological, functional, and quality of life questionnaires. This work will be based on a collaboration between the Universities of Saint Etienne (L. Féasson), Grenoble (B Wuyam) and Örebro (F Kadi) within the Rhône-Alpes Reference Centre for Rare Neuromuscular Diseases (JC Antoine).

It is accepted that exercise therapy can be recommended for patients with myopathies but long-term training load still has to be determined for each pathology. In the specific context of facioscapulohumeral dystrophy, we aim at associating the scientific evaluation of physical activity benefits and a therapeutic education of patients in order to contribute to recommendations for physicians and physiotherapists. The purpose of this study is to combine an integrated approach with a better understanding of biological process implicated in this physiological treatment strategy.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Exercise and Myopathies. Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients: Functional, Tissue and Quality of Life Benefits.
Study Start Date : October 2010
Actual Primary Completion Date : January 2015
Actual Study Completion Date : January 2015

Arm Intervention/treatment
Experimental: Physical training
The training will consist in 3 sessions of 35 min of training per week at home on an ergocycle. As a result, lower limb muscles will be mainly solicited. These muscles are heterogeneous in terms of deficiency, but this latter is compatible with cycling. The training will be divided in (i) 2 sessions of 30 min aerobic exercises at a constant but moderate (60% of maximal aerobic power, MAP) intensity followed with 5 sets of 10 revolutions at near-maximal intensity and (ii) an interval-training session. This latter session will consist in 5 min warm-up at 40% MAP followed by 5 times 1 min at 80% MAP (recovery = 4 min at 40% MAP) followed by 5 min of active recovery. Over a 2 to 4 weeks initial period, the program will be conducted in the laboratory or at home under the supervision of a coach. Then a systematic supervision of the sessions by the coach will be performed by phone, by using the heart rate recordings and values of Analogic Visual Scale for pain and fatigue.
Other: Physical training
Physical training during 24 weeks

None intervention
Other: Control
No intervention

Primary Outcome Measures :
  1. maximal oxygen uptake (VO2max) [ Time Frame: Week 24 ]
    VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle

Secondary Outcome Measures :
  1. Questionnaire of quality of life [ Time Frame: Day 0, Week 6, Week 12, Week 18 and Week 24 ]
    "short form 36 health survey questionnaire" SF36

  2. Biopsy [ Time Frame: Day 0 and Week 24 ]
    biopsy of the vastus lateralis muscle

  3. maximal oxygen uptake (VO2max) [ Time Frame: Week 6, Week 12 and Week 18 ]
    VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle

  4. Questionnaire of subjective fatigue [ Time Frame: Day 0, Week 6, Week 12, Week 18 and Week 24 ]
    Fatigue severity scale (FSS)

  5. nuclear magnetic resonance imaging [ Time Frame: Inclusion ]
    In Paris centre, a total body NMR imaging will be done with standard T2- and T1-weighted images.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • facioscapulohumeral dystrophy
  • Being capable of supporting an exercise on ergocycle
  • Social Security regimen affiliated
  • Consent form signed

Exclusion Criteria:

  • Severe cardiac or respiratory insufficiency
  • Cardiac pacemaker
  • Morbid obesity (BMI upper to 35)
  • Anti platelet therapy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01116570

Layout table for location information
CHU de Grenoble
Grenoble, France, 38000
CHU de Saint-Etienne
Saint-etienne, France, 42055
Sponsors and Collaborators
Centre Hospitalier Universitaire de Saint Etienne
Association Française contre les Myopathies (AFM), Paris
Örebro University, Sweden
Layout table for investigator information
Principal Investigator: Leonard FEASSON, MD-PhD CHU de Saint-Etienne
Study Chair: Fawzi KADI, MD-PhD Orebro University, Sweden

Layout table for additonal information
Responsible Party: Centre Hospitalier Universitaire de Saint Etienne Identifier: NCT01116570     History of Changes
Other Study ID Numbers: 1001035
2010-A00288-31 ( Other Identifier: AFSSAPS )
2009.1087-14263 ( Other Grant/Funding Number: AFM )
First Posted: May 5, 2010    Key Record Dates
Last Update Posted: April 1, 2015
Last Verified: March 2015
Keywords provided by Centre Hospitalier Universitaire de Saint Etienne:
Muscular Dystrophy
Physical training
Additional relevant MeSH terms:
Layout table for MeSH terms
Muscular Dystrophies
Muscular Dystrophy, Facioscapulohumeral
Muscular Disorders, Atrophic
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases
Genetic Diseases, Inborn